Researchers and Laboratories
Dr. Abel conducts clinical, translational, and basic research in urologic oncology. Clinical and translational interests include improving patient outcomes after complex urologic surgery, improving prognostic ability for patient decision making, and multidisciplinary care of kidney cancer.
Dr. Abel serves on the board of directors for the Society of Urologic Oncology (SUO) Clinical Trials Consortium.
Dr. Best’s research interests lie in the study of kidney cancer and disease using optics, the development of new technology for minimally invasive surgery, and urinary stone disease.
Inflammation of the bladder due to non-infectious causes, and mechanisms that modulate pain sensation and bladder healing. The laboratory’s primary research emphasis is the causes and pathogenesis of non-infectious cystitis and and the effects of infectious cystitis on the afferent nervous system. Clinical disorders of particular relevance to models used in the laboratory include urinary tract infection, Interstitial Cystitis (IC) in women, and Feline Urologic Syndrome (FUS) in cats. The goalsof this research are to identify processes that promote inflammation, damage, and pain within the bladder and to investigate improved therapeutic modalities for treatment or prevention of symptoms assocated with cystitis.
Dr. Borza is a health services researcher with a focus is on understanding how health policy changes impact surgical care and, more specifically, care of urologic malignancies. His current projects revolve around improving opioid medication stewardship by engaging surgeons through the Surgical Collaborative of Wisconsin. Additionally, he is working on understanding how different components of the Affordable Care Act have impacted treatment patterns and readmissions among patients undergoing major surgical procedures.
Dr. Bruskewitz is studying surgical and pharmacological therapies for benign prostatic hyperplasia, with funding from the National Insitutes of Health, major pharmaceutical companies, and various study groups.
Dr. Bushman’s research interests include clinical research in bladder and pelvic floor dysfunction and basic research in prostate development and prostate cancer.
Dr. Downs has a joint appointment with the UW Carbone Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers.
Chemoprevention – Bladder cancer, prostate cancer
Screening Programs – Bladder cancer screening for high-risk subjects
Outcomes Research – Patient outcomes of treatments for non-muscle invasive (superficial) bladder cancer and radical cystectomy
Translational Research – Discovery of molecular and urinary biomarkers (bladder cancer)
Quality of Life Outcomes – Bladder cancer, prostate cancer
Dr. Jarrard has a joint appointment with the University of Wisconsin Comprehensive Cancer Center, and his clinical research emphasizes developing novel diagnostics and new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health and Department of Defense to examine genetic and epigenetic alterations in prostate cancer.
Dr. McAchran’s research interests in female urology include optimization of care pathways to improve surgical outcomes and clinical outcomes of female pelvic floor reconstruction.
Dr. Nakada’s research focuses on pathophysiology of the ureter and all aspects of urinary stone disease. His research is currently supported by the American Urologic Association.
Dr. Paolone’s research interests are in the areas of Benign Prostate Hyperplasia (BPH) and penile disorders.
Dr. Penniston’s research interests include clinical nutrition research in kidney stones and prostate cancer. Specifically, she is interested in the efficacy of nutrition therapy in the prevention, management, and treatment of disease and on indicators of quality of life.
Dr. Richards conducts clinical, translational and health services research in urologic oncology. He has special interests in quality improvement projects aimed at streamlining health care delivery and efficiency for all patients with urologic malignancies.
Dr. Ricke’s research interests include prostate cancer.
Dr. Su’s research interests include urinary tract infections, disorders of sexual development, outcomes analysis of complex urologic reconstruction, clinical epidemiology, and translational science.
Dr. Williams’ research interests in male infertility include the preservation of fertility in men with cancer, the effects of advanced paternal age and the environment on male reproductive potential, and clinical outcomes of male reproductive tract reconstructions.